Buckley Wealth Management’s Boston Scientific BSX Stock Holding History

Buckley Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,737	Closed	-$261K	–	105
2025 Q4	$261K	Hold	2,737	–	–	0.07%	95
2025 Q3	$267K	Sell	2,737 -1,110	-29%	-$115K	0.07%	96
2025 Q2	$413K	Sell	3,847 -82	-2%	-$8.3K	0.12%	90
2025 Q1	$396K	Sell	3,929 -329	-8%	-$33.1K	0.12%	88
2024 Q4	$380K	Sell	4,258 -533	-11%	-$46.9K	0.12%	87
2024 Q3	$401K	Hold	4,791	–	–	0.12%	85
2024 Q2	$369K	Sell	4,791 -14	-0.3%	-$1.02K	0.12%	89
2024 Q1	$329K	Sell	4,805 -1,156	-19%	-$74.3K	0.11%	92
2023 Q4	$345K	Sell	5,961 -148	-2%	-$7.9K	0.12%	91
2023 Q3	$323K	Sell	6,109 -6,679	-52%	-$350K	0.12%	90
2023 Q2	$692K	Buy	12,788 +6,264	+96%	+$327K	0.24%	75
2023 Q1	$326K	Buy	6,524 +1,762	+37%	+$83K	0.12%	91
2022 Q4	$220K	Buy	+4,762	New	+$206K	0.08%	100
2022 Q3	–	Sell	-10,126	Closed	-$377K	–	114
2022 Q2	$377K	Buy	10,126 +3,752	+59%	+$153K	0.12%	103
2022 Q1	$282K	Buy	+6,374	New	+$276K	0.08%	127

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Buckley Wealth Management's BSX Position: Q1 2026 in Review

Buckley Wealth Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,737 shares — an estimated $261K sold.

Buckley Wealth Management first reported a position in BSX in Q1 2022 and held it in 15 quarters. The position peaked at $692K in Q2 2023. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Buckley Wealth Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Buckley Wealth Management sold 2,737 Boston Scientific shares in Q1 2026, an estimated $261K.
Buckley Wealth Management first reported a position in Boston Scientific in Q1 2022 and held it in 15 quarters.
Buckley Wealth Management's Boston Scientific position peaked at $692K in Q2 2023.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Buckley Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.